| LGVAX | RWMHX | LGVAX / RWMHX | |
| Total Expense Ratio | 1.01 | 0.41 | 246% |
| Annual Report Gross Expense Ratio | 1.04 | 0.41 | 254% |
| Fund Existence | 17 years | 11 years | - |
| Gain YTD | 11.332 | 6.022 | 188% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 4.2B | 218B | 2% |
| Annual Yield % from dividends | 1.21 | 1.32 | 92% |
| Returns for 1 year | 11.30 | 11.20 | 101% |
| Returns for 3 years | 17.12 | 31.01 | 55% |
| Returns for 5 years | -5.51 | 26.60 | -21% |
| Returns for 10 years | 76.65 | 86.39 | 89% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BEXUX | 22.61 | 0.31 | +1.39% |
| Baron Emerging Markets R6 | |||
| VSIAX | 103.72 | 0.94 | +0.91% |
| Vanguard Small Cap Value Index Admiral | |||
| TRZYX | 23.77 | 0.21 | +0.89% |
| T. Rowe Price Latin America Z | |||
| PIGDX | 4.55 | 0.03 | +0.66% |
| Federated Hermes International Growth IS | |||
| VLMIX | 34.36 | -0.06 | -0.17% |
| Value Line Mid Cap Focused Institutional | |||